Drug Use and Addiction Research Programs
Open Opportunities (36)
Live Grants.gov opportunities funded under this program — you can apply now.
- HEAL: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 – Clinical Trial Optional) Deadline: Jun 9, 2026
- Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Study Renewal – Data Analysis, Informatics and Resource Center, and Coordinating Center (U24 Clinical Trial Not Al Deadline: Jun 10, 2026
- Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Study-Research Project Sites (U01 Clinical Trial Not Allowed) Deadline: Jun 10, 2026
- BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) Deadline: Jun 16, 2026
- BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) Deadline: Jun 16, 2026
- Exploratory Clinical Neuroscience Research on Substance Use Disorders Deadline: Jul 10, 2026
- Avant Garde/Avenir award for Investigators conducting high risk/high reward research on HIV and Substance Use (or Substance Use Disorders) Deadline: Aug 15, 2026
- Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) Deadline: Sep 7, 2026
- NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access Deadline: Sep 8, 2026
- NIDA Core "Center of Transformative Science" Grant Program Deadline: Sep 25, 2026
- Growing Great Ideas: Research Education Course in Product Development and Entrepreneurship for Life Science Researchers Deadline: Oct 1, 2026
- Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials Deadline: Oct 2, 2026
- Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances Deadline: Oct 7, 2026 · up to $700K
- Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Chemical or Radiation/Nuclear (CRN) Threats Deadline: Oct 9, 2026
- NIH Blueprint Initiative: Tools for Germline Gene Editing in the Nervous System Deadline: Oct 12, 2026 · up to $1.2M
- Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) Deadline: Oct 30, 2026
- HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) – Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center Deadline: Nov 2, 2026
- HEAL Initiative: Integrative Management of Chronic Pain and Opioid Use Disorder (OUD) for Whole Recovery: Health Systems Deadline: Nov 2, 2026
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) Deadline: Nov 13, 2026 · up to $750K
- BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 – Clinical Trial Not Allowed) Deadline: Jan 28, 2027 · up to $750K
- NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) Deadline: Feb 11, 2027
- High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) Deadline: Mar 5, 2027 · up to $1.5M
- High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) Deadline: Mar 6, 2027
- Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required) Deadline: Mar 16, 2027
- Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) Deadline: May 7, 2027
- Independent Scientist Award (Parent K02 – Independent Clinical Trial Required) Deadline: May 7, 2027
- Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) Deadline: Aug 11, 2027 · up to $150K
- D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional) Deadline: Sep 7, 2027 · up to $100K
- Intervention Research to Improve Native American Health Deadline: Oct 18, 2027
- NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) Deadline: Nov 12, 2027 · up to $350K
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) Deadline: Jan 7, 2028
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) Deadline: Jan 7, 2028
- Imaging – Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) Deadline: Jan 7, 2028 · up to $150K
- Blueprint MedTech Translator (UG3/UH3 – Clinical Trial Optional) Deadline: Jan 28, 2028
- Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 – Clinical Trial Optional) Deadline: Aug 21, 2028 · up to $3M
- NIH Science Education Partnership Award (SEPA) (R25 – Clinical Trial Not Allowed) Deadline: May 25, 2029
Program Funding
Annual program obligations reported to SAM.gov.
Who has received this funding
Organizations awarded under CFDA 93.279 (USAspending.gov).
- New York University $128,078,833
- Yale Univ $126,585,435
- University Of Kentucky Research Foundation, The $79,333,238
- Boston Medical Center Corporation $78,351,755
- The Trustees Of Columbia University In The City Of New York $74,806,844
- The University Of Texas Southwestern Medical Center $71,588,047
- Ohio State University, The $61,578,651
- University Of Miami $50,344,757
- Hennepin Healthcare Research Institute $41,820,011
- Regents Of The University Of Michigan $39,479,041
Program Objective
To support basic, clinical, translational, and implementation research in the field of substance use. To develop new knowledge and approaches for the prevention, diagnosis, and treatment of drug use, misuse, and addiction, drug overdose, and related health outcome, including HIV/AIDS. To support research training and research scientist development. To support dissemination of research findings.
Small Business Innovation Research (SBIR) legislation is intended to expand and improve the SBIR programs to emphasize and increase private sector commercialization of technology developed through Federal SBIR research and development; increase small business participation in Federal research and development; and foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in the SBIR program. The Small Business Technology Transfer (STTR) legistlation is intended to stimulate and foster scientific and technological innovation through cooperative research and development carried out between small business concerns and research institutions; foster technology transfer between small business concerns and research institutions; increase private sector commercialization of innovations derived from Federal research and development; and foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation.
Eligibility
Eligible Applicants
- Nonprofit Organization
- U.S. State Government
- U.S. Territory Government
- Federally Recognized Tribal Government
- Tribal Government (other)
- Tribally Designated Housing Authority
- Municipality/Township Government
- Public Housing Authority
- Foreign Nonprofit Organization
- Foreign Not-for-Profit Organization
- Foreign For-Profit Organization
- Not-for-Profit Organization
- For-Profit Organization
- Other
Eligible organizations determined at the NOFO level
How to Apply
Award Procedure
Grants with which the National Advisory Council on Drug Abuse has concurred with the recommendations of the Scientific Review Groups and approved by NIDA for payment are awarded directly by NIDA to the applicant institution. SBIR/STTR applications are evaluated for scientific and technical merit by an appropriate scientific peer review panel and by the National Advisory Council. All applications receiving a priority score compete for available SBIR/STTR set-aside funds on the basis of scientific and technical merit and commercial potential of the proposed research, program relevance, and program balance among the areas of research.
From 240 to 270 days from submission of grant application. For AIDS applications the range will not exceed 180 days from cited receipt dates. SBIR/STTR applications: About 225 days.
Program details & compliance
Description
To support basic, clinical, translational, and implementation research in the field of substance use. To develop new knowledge and approaches for the prevention, diagnosis, and treatment of drug use, misuse, and addiction, drug overdose, and related health outcome, including HIV/AIDS.
Mission Categories
Primary: Prevention and Control (includes Suicide Prevention)
Other categories:
BiologyResearch and DevelopmentSocial Sciences
Use of Funds
Allowed Uses
(1) Research project grants provide support for clearly defined projects or a small group of related research activities, and when appropriate, support of research conferences; (2) program project and center grants support large-scale, broad-based programs of research, usually interdisciplinary, consisting of several projects with a common focus; (3) small grants support newer, less experienced investigators; investigators at institutions without a well-developed research tradition and resources; the testing of new methods or techniques; small-scale exploratory and pilot studies, or exploration of an unusual research opportunity; (4) research training grants including fellowships and institutional training grants, career development grants and loan repayment contracts; (5) SBIR Phase I grants (of approximately 6-months' duration) are to establish the technical merit and feasibility of proposed research or research and development efforts to determine the quality of performance of the small business grantees. Phase II grants are for the continuation of the research initiated in Phase I and that are likely to result in commercially viable products or processes. STTR Phase I grants (normally of 1-year duration) are to determine the scientific, technical, and commercial merit and feasibility of the proposed cooperative effort that has potential for commercial application and the quality of performance of the small business concerns. Phase II funding is based on results of research initiated in Phase I and scientific and technical merit and commercial potential of the Phase II application.
Reporting & Compliance
Applicable 2 CFR 200 Subparts
- Subpart B — General Provisions
- Subpart C — Pre-Federal Award Requirements
- Subpart D — Post-Federal Award Requirements
- Subpart E — Cost Principles
- Subpart F — Audit Requirements